Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

126.97
BATS BZX Real-Time Price
As of 1:16pm ET
 +2.34 / +1.88%
Today’s Change
65.91
Today|||52-Week Range
151.75
+40.45%
Year-to-Date

Today’s Trading

Previous close124.63
Today’s open126.43
Day’s range124.43 - 127.70
Volume343,473
Average volume (3 months)1,314,818
Market cap$20.1B
Dividend yield--
Data as of 1:03pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)+28.13%
Earnings growth (this year)-146.28%
Earnings growth (next 5 years)+29.97%
Revenue growth (last year)+36.76%
P/E ratioNM
Price/Sales17.64
Price/Book12.16

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+3.60+3.13%
ZTSZoetis Inc+0.65+1.48%
MYLMylan NV+0.27+0.56%
HSPHospira Inc+0.01+0.01%
Data as of 1:20pm ET, 09/02/2015

Financials

Next reporting dateOctober 22, 2015
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$750.0M
Annual profit (last year)-$134.0M
Net profit margin-17.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts

Partner Offers